Suven Pharmaceuticals
Suven Pharmaceuticals Limited is a bio-pharmaceutical company based in Hyderabad, India, with operations extending to the United States, Europe, and other international markets. Founded in 2018, the company focuses on the development, manufacturing, and sale of new chemical entity intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs. Suven Pharmaceuticals operates primarily through contract research and manufacturing services, catering to the needs of pharmaceutical, biotechnology, and chemical companies. As a subsidiary of Jasti Property and Equity Holdings Private Limited, the company strives to meet customer demands and expectations in the pharmaceutical industry.
2 past transactions
NJ Bio
Acquisition in 2024
NJ Bio, Inc. is a contract research organization (CRO) and contract development and manufacturing organization (CDMO) that specializes in integrated chemistry and biology services tailored for the biotech and pharmaceutical industries. The company offers a comprehensive suite of services, including multistep organic synthesis, medicinal chemistry, bioconjugation, antibody-drug conjugates, protein production, cell-based assays, and bioanalytical services. By providing these capabilities, NJ Bio aims to facilitate and accelerate the product development processes for its clients, addressing their research needs effectively.
Casper Pharma
Acquisition in 2024
Casper Pharma is an emerging specialty pharmaceutical company dedicated to enhancing patients' lives through the development, acquisition, and commercialization of pharmaceuticals. The company operates within several therapeutic areas, including cardiovascular, gastrointestinal, urological, pain management, and ophthalmic markets. By leveraging its global network, Casper Pharma aims to address unmet medical needs and provide effective therapeutic solutions for its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.